Search

Your search keyword '"Fournier, Laure"' showing total 489 results

Search Constraints

Start Over You searched for: Author "Fournier, Laure" Remove constraint Author: "Fournier, Laure"
489 results on '"Fournier, Laure"'

Search Results

2. METhodological RadiomICs Score (METRICS): a quality scoring tool for radiomics research endorsed by EuSoMII

3. Strategies to safely rule out pulmonary embolism in COVID-19 outpatients: a multicenter retrospective study

10. Attitudes and perceptions of radiologists towards online (virtual) oncologic multidisciplinary team meetings during the COVID-19 pandemic—a survey of the European Society of Oncologic Imaging (ESOI)

11. AI-Driven CT-based quantification, staging and short-term outcome prediction of COVID-19 pneumonia

12. Designing clinical trials based on modern imaging and metastasis-directed treatments in patients with oligometastatic breast cancer: a consensus recommendation from the EORTC Imaging and Breast Cancer Groups

15. Validated imaging biomarkers as decision-making tools in clinical trials and routine practice: current status and recommendations from the EIBALL* subcommittee of the European Society of Radiology (ESR).

16. Nivolumab, nivolumab–ipilimumab, and VEGFR-tyrosine kinase inhibitors as first-line treatment for metastatic clear-cell renal cell carcinoma (BIONIKK): a biomarker-driven, open-label, non-comparative, randomised, phase 2 trial

18. Standardised lesion segmentation for imaging biomarker quantitation: a consensus recommendation from ESR and EORTC

20. A Proposal for a Process from as Low as Reasonably Achievable to an Ultra-Low-Level Goal in Chest Computed Tomography.

25. Incorporating radiomics into clinical trials: expert consensus endorsed by the European Society of Radiology on considerations for data-driven compared to biologically driven quantitative biomarkers

30. Ovarian and peritoneal psammocarcinoma: Results of a multicenter study on 25 patients

32. Longitudinal Study of Advanced Non-Small Cell Lung Cancer with Initial Durable Clinical Benefit to Immunotherapy: Strategies for Anti-PD-1/PD-L1 Continuation beyond Progression

33. Impact of the COVID-19 crisis on imaging in oncological trials

34. List of contributors

36. Texte court rédigé à partir de la recommandation nationale de bonnes pratiques cliniques « Conduites à tenir initiales devant des patientes atteintes d’un cancer épithélial de l’ovaire » élaborée par FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY et labélisée par l’INCa »

44. Figure S1 from Sunitinib Prior to Planned Nephrectomy in Metastatic Renal Cell Carcinoma: Angiogenesis Biomarkers Predict Clinical Outcome in the Prospective Phase II PREINSUT Trial

45. Table S4 from Sunitinib Prior to Planned Nephrectomy in Metastatic Renal Cell Carcinoma: Angiogenesis Biomarkers Predict Clinical Outcome in the Prospective Phase II PREINSUT Trial

46. Supplementary data from In Vivo Detection of Succinate by Magnetic Resonance Spectroscopy as a Hallmark of SDHx Mutations in Paraganglioma

47. Post-progression survival in advanced non-small cell lung cancer treated with anti-PD-1/PDL-1 monotherapy: progression after durable clinical benefit versus primary resistance

50. « Big data » et « open data » : quel accès pour la recherche ?

Catalog

Books, media, physical & digital resources